Perrigo Net Income 2010-2025 | PRGO

Perrigo net income from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Perrigo Annual Net Income
(Millions of US $)
2024 $-172
2023 $-13
2022 $-141
2021 $-69
2020 $-163
2019 $146
2018 $131
2017 $120
2016 $-4,013
2015 $43
2015 $136
2014 $233
2013 $442
2012 $402
2011 $339
2010 $224
2009 $146
Perrigo Quarterly Net Income
(Millions of US $)
2025-03-31 $-6
2024-12-31 $-44
2024-09-30 $-21
2024-06-30 $-108
2024-03-31 $2
2023-12-31 $-32
2023-09-30 $14
2023-06-30 $8
2023-03-31 $-3
2022-12-31 $-24
2022-09-30 $-49
2022-06-30 $-65
2022-03-31 $-2
2021-12-31 $10
2021-09-30 $-59
2021-06-30 $-58
2021-03-31 $38
2020-12-31 $-175
2020-09-30 $-155
2020-06-30 $61
2020-03-31 $106
2019-12-31 $-19
2019-09-30 $92
2019-06-30 $9
2019-03-31 $64
2018-12-31 $82
2018-09-30 $-68
2018-06-30 $36
2018-03-31 $81
2017-12-31 $73
2017-09-30 $45
2017-06-30 $-70
2017-03-31 $72
2016-12-31 $-1,359
2016-09-30 $-1,590
2016-06-30 $-534
2016-03-31 $-529
2015-12-31 $-174
2015-09-30 $261
2015-06-30 $-22
2015-03-31 $-22
2014-12-31 $70
2014-09-30 $96
2014-06-30
2014-03-31 $48
2013-12-31 $-86
2013-09-30 $111
2013-06-30
2013-03-31 $112
2012-12-31 $106
2012-09-30 $106
2012-06-30
2012-03-31 $116
2011-12-31 $100
2011-09-30 $70
2011-06-30
2011-03-31 $89
2010-12-31 $90
2010-09-30 $74
2010-06-30
2010-03-31 $62
2009-12-31 $61
2009-09-30 $52
2009-06-30
2009-03-31 $46
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.676B $4.373B
Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.616B 27.97
Boston Scientific (BSX) United States $153.611B 38.46
Stryker (SYK) United States $149.817B 31.33
EssilorLuxottica (ESLOY) France $128.259B 0.00
Medtronic (MDT) Ireland $112.441B 15.94
Lonza Group Ag (LZAGY) Switzerland $50.320B 0.00
Haleon (HLN) United Kingdom $45.596B 26.03
ResMed (RMD) United States $37.597B 28.24
GE HealthCare Technologies (GEHC) United States $34.163B 16.22
Agilent Technologies (A) United States $33.875B 22.08
Terumo (TRUMY) Japan $24.770B 32.17
Koninklijke Philips (PHG) Netherlands $22.956B 16.11
Insulet (PODD) United States $21.162B 83.07
Zimmer Biomet Holdings (ZBH) United States $18.315B 11.76
Baxter (BAX) United States $15.236B 11.38
Smith & Nephew SNATS (SNN) United Kingdom $13.113B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.723B 23.40
Lantheus Holdings (LNTH) United States $5.479B 13.82
Prestige Consumer Healthcare (PBH) United States $3.900B 17.42
Haemonetics (HAE) United States $3.609B 16.44
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.334B 27.70
ICU Medical (ICUI) United States $3.192B 23.54
QuidelOrtho (QDEL) United States $1.976B 13.59
LeMaitre Vascular (LMAT) United States $1.875B 41.91
AtriCure (ATRC) United States $1.561B 0.00
Acuren (TIC) United States $1.375B 0.00
AdaptHealth (AHCO) United States $1.248B 12.67
Phibro Animal Health (PAHC) United States $1.212B 15.49
Green Thumb Industries (GTBIF) United States $1.163B 26.16
Neogen (NEOG) United States $1.081B 13.83
BioLife Solutions (BLFS) United States $1.036B 0.00
InMode (INMD) Israel $0.954B 9.62
Kestra Medical Technologies (KMTS) United States $0.757B 0.00
Owens & Minor (OMI) United States $0.669B 5.55
Maravai LifeSciences Holdings (MRVI) United States $0.662B 0.00
CeriBell (CBLL) United States $0.622B 0.00
Evolus (EOLS) United States $0.589B 0.00
Curaleaf Holdings (CURLF) Canada $0.553B 0.00
Tilray Brands (TLRY) Canada $0.507B 0.00
Valneva SE (VALN) France $0.488B 0.00
Capricor Therapeutics (CAPR) United States $0.452B 0.00
Surmodics (SRDX) United States $0.424B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.360B 0.00
VAREX IMAGING (VREX) United States $0.344B 12.67
SNDL (SNDL) Canada $0.326B 0.00
Quanterix (QTRX) United States $0.315B 0.00
Sanuwave Health (SNWV) United States $0.284B 0.00
Cerus (CERS) United States $0.277B 0.00
Viemed Healthcare (VMD) United States $0.272B 22.90
ZimVie (ZIMV) United States $0.263B 11.94
Sanara MedTech (SMTI) United States $0.259B 0.00
Brainsway (BWAY) Israel $0.253B 66.85
Aurora Cannabis (ACB) Canada $0.249B 73.83
Cresco Labs (CRLBF) United States $0.247B 0.00
OraSure Technologies (OSUR) United States $0.228B 0.00
Canopy Growth (CGC) Canada $0.221B 0.00
Biote (BTMD) United States $0.218B 6.14
TriSalus Life Sciences (TLSI) United States $0.188B 0.00
High Tide (HITI) Canada $0.188B 0.00
Organigram Global (OGI) Canada $0.186B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.13
Omeros (OMER) United States $0.180B 0.00
Verano Holdings (VRNOF) United States $0.173B 0.00
Exagen (XGN) United States $0.148B 0.00
Vireo Growth (VREOF) United States $0.147B 0.00
FitLife Brands (FTLF) United States $0.129B 15.90
Apyx Medical (APYX) United States $0.098B 0.00
Fonar (FONR) United States $0.096B 12.37
Jin Medical (ZJYL) China $0.090B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
TerrAscend (TSNDF) Canada $0.088B 0.00
MacroGenics (MGNX) United States $0.086B 0.00
Veru (VERU) United States $0.086B 0.00
Zynex (ZYXI) United States $0.076B 0.00
Quipt Home Medical (QIPT) United States $0.075B 0.00
Agape ATP (ATPC) $0.070B 0.00
InterCure (INCR) Israel $0.068B 0.00
Cytosorbents (CTSO) United States $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.059B 0.00
Nephros (NEPH) United States $0.043B 58.29
Modular Medical (MODD) United States $0.040B 0.00
Safety Shot (SHOT) United States $0.038B 0.00
United-Guardian (UG) United States $0.038B 13.10
Rockwell Medical (RMTI) United States $0.027B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
INLIF (INLF) $0.015B 0.00
IM Cannabis (IMCC) Canada $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Senestech (SNES) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00